HomeSHTDY • OTCMKTS
add
Sinopharm Group ADR
Previous close
$11.62
Day range
$11.15 - $11.96
Year range
$10.13 - $16.31
Market cap
56.01B HKD
Avg Volume
26.48K
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 141.66B | -3.81% |
Operating expense | 6.72B | -6.59% |
Net income | 1.46B | 2.59% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 3.70B | -5.19% |
Effective tax rate | 23.38% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.36B | -32.44% |
Total assets | 415.08B | — |
Total liabilities | 285.93B | — |
Total equity | 129.16B | — |
Shares outstanding | 3.12B | — |
Price to book | 0.45 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.46B | 2.59% |
Cash from operations | -34.28B | 27.81% |
Cash from investing | 617.49M | 141.09% |
Cash from financing | 12.88B | -41.88% |
Net change in cash | -20.78B | 17.10% |
Free cash flow | -14.13B | — |
About
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Founded
2003
Website
Employees
108,217
